Literature DB >> 8617709

Reducing the risk of drug-drug interactions: a goal of rational drug development.

S H Preskorn1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8617709

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  2 in total

Review 1.  Recent developments in the management of psychosis.

Authors:  M J Hoes
Journal:  Pharm World Sci       Date:  1998-06

2.  Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.

Authors:  Mahnaz Salsali; Andrew Holt; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.